000 | 01601 a2200481 4500 | ||
---|---|---|---|
005 | 20250516052148.0 | ||
264 | 0 | _c20120224 | |
008 | 201202s 0 0 eng d | ||
022 | _a1543-8392 | ||
024 | 7 |
_a10.1021/mp200209j _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSmith, Adam J | |
245 | 0 | 0 |
_aCocrystals of quercetin with improved solubility and oral bioavailability. _h[electronic resource] |
260 |
_bMolecular pharmaceutics _cOct 2011 |
||
300 |
_a1867-76 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntioxidants _xanalysis |
650 | 0 | 4 |
_aCaffeine _xchemistry |
650 | 0 | 4 | _aCalorimetry, Differential Scanning |
650 | 0 | 4 | _aChemical Phenomena |
650 | 0 | 4 | _aCrystallography, X-Ray |
650 | 0 | 4 |
_aDietary Supplements _xanalysis |
650 | 0 | 4 | _aHalf-Life |
650 | 0 | 4 | _aIntestinal Absorption |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMethanol _xchemistry |
650 | 0 | 4 | _aMolecular Conformation |
650 | 0 | 4 |
_aNiacinamide _xchemistry |
650 | 0 | 4 | _aPowder Diffraction |
650 | 0 | 4 |
_aQuercetin _xblood |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aSolubility |
650 | 0 | 4 | _aSpectroscopy, Fourier Transform Infrared |
650 | 0 | 4 |
_aTheobromine _xchemistry |
700 | 1 | _aKavuru, Padmini | |
700 | 1 | _aWojtas, Lukasz | |
700 | 1 | _aZaworotko, Michael J | |
700 | 1 | _aShytle, R Douglas | |
773 | 0 |
_tMolecular pharmaceutics _gvol. 8 _gno. 5 _gp. 1867-76 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/mp200209j _zAvailable from publisher's website |
999 |
_c21089851 _d21089851 |